AAAAAA

   
Results: 1-17 |
Results: 17
Effect of ibandronate on bone loss and renal function after kidney transplantation
Authors: Grotz, W Nagel, C Poeschel, D Cybulla, M Petersen, KG Uhl, M Strey, C Kirste, G Olschewski, M Reichelt, A Rump, LC
Citation: W. Grotz et al., Effect of ibandronate on bone loss and renal function after kidney transplantation, J AM S NEPH, 12(7), 2001, pp. 1530-1537
A patient with neurological deficits and seizures after renal transplantation
Authors: Manz, T Grotz, W Orszagh, M Volk, B Kirste, G Neumann, HPH
Citation: T. Manz et al., A patient with neurological deficits and seizures after renal transplantation, NEPH DIAL T, 16(3), 2001, pp. 631-633
Crossover renal transplantation: Hurdles to be cleared!
Authors: Thiel, G Vogelbach, P Gurke, L Gasser, T Lehmann, K Voegele, T Kiss, A Kirste, G
Citation: G. Thiel et al., Crossover renal transplantation: Hurdles to be cleared!, TRANSPLAN P, 33(1-2), 2001, pp. 811-816
Cytomegalovirus PP65 antigen-guided preemptive therapy with ganciclovir insolid organ transplant recipients: A prospective, double-blind, placebo-controlled study
Authors: Koetz, AC Delbruck, R Furtwangler, A Hufert, FT Neumann-Haefelin, D Kirste, G Meyer-Konig, U
Citation: Ac. Koetz et al., Cytomegalovirus PP65 antigen-guided preemptive therapy with ganciclovir insolid organ transplant recipients: A prospective, double-blind, placebo-controlled study, TRANSPLANT, 72(7), 2001, pp. 1325-1327
Mycophenolate mofetil in pediatric renal transplantation without inductiontherapy: Results after 12 months of treatment
Authors: Staskewitz, A Kirste, G Tonshoff, B Weber, LT Boswald, M Burghard, R Helmchen, U Brandis, M Zimmerhackl, LB
Citation: A. Staskewitz et al., Mycophenolate mofetil in pediatric renal transplantation without inductiontherapy: Results after 12 months of treatment, TRANSPLANT, 71(5), 2001, pp. 638-644
VHL c.505 T > C mutation confers a high age related penetrance but no increased overall mortality
Authors: Bender, BU Eng, C Olschewski, M Berger, DP Laubenberger, J Altehofer, C Kirste, G Orszagh, M van Velthoven, V Miosczka, H Schmidt, D Neumann, HPH
Citation: Bu. Bender et al., VHL c.505 T > C mutation confers a high age related penetrance but no increased overall mortality, J MED GENET, 38(8), 2001, pp. 508-514
Preoperative examination of potential renal transplant donors: Value of gadolinium-enhanced 3D-MR-Angiography in comparison with DSA and urography.
Authors: Winterer, JT Strey, C Wolffram, C Paul, G Einert, A Altehoefer, C Uhrmeister, P Kirste, G Laubenberger, J
Citation: Jt. Winterer et al., Preoperative examination of potential renal transplant donors: Value of gadolinium-enhanced 3D-MR-Angiography in comparison with DSA and urography., ROFO-F RONT, 172(5), 2000, pp. 449-457
Dihydropyridine calcium antagonists and renal function in hypertensive kidney transplant recipients
Authors: Rump, LC Oberhauser, V Schwertfeger, E Speidel, L Zimmerhackl, L Kirste, G Grotz, W
Citation: Lc. Rump et al., Dihydropyridine calcium antagonists and renal function in hypertensive kidney transplant recipients, J HYPERTENS, 18(8), 2000, pp. 1115-1119
Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas
Authors: Bender, BU Gutsche, M Glasker, S Muller, B Kirste, G Eng, C Neumann, HPH
Citation: Bu. Bender et al., Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas, J CLIN END, 85(12), 2000, pp. 4568-4574
Living-donor kidney transplantation
Authors: Kirste, G
Citation: G. Kirste, Living-donor kidney transplantation, LANG ARCH S, 384(6), 1999, pp. 523-527
Influence of cytokines on the expression of Fas ligand and CD44 splice variants in colon carcinoma cells
Authors: Wimmenauer, S Steiert, A Wolff-Vorbeck, G Xing, BC Baier, PK Ruckauer, KD Kirste, G von Kleist, S
Citation: S. Wimmenauer et al., Influence of cytokines on the expression of Fas ligand and CD44 splice variants in colon carcinoma cells, TUMOR BIOL, 20(6), 1999, pp. 294-303
Living donation in kidney transplantation
Authors: Kirste, G
Citation: G. Kirste, Living donation in kidney transplantation, NIEREN HOCH, 28(8), 1999, pp. 300-305
Living donors in organ transplantation
Authors: Kirste, G
Citation: G. Kirste, Living donors in organ transplantation, ZBL CHIR, 124(8), 1999, pp. 716-717
Living donors for renal transplantation. The surgical procedure
Authors: Baier, PK Pisarski, P Wimmenauer, S Kirste, G
Citation: Pk. Baier et al., Living donors for renal transplantation. The surgical procedure, ZBL CHIR, 124(8), 1999, pp. 729-733
A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation - A report of the European anti-ICAM-1 renal transplant study group
Authors: Salmela, K Wramner, L Ekberg, F Hauser, I Bentdal, O Lins, LE Isoniemi, H Backman, L Persson, N Neumayer, HH Jorgensen, PF Spieker, C Hendry, B Nicholls, A Kirste, G Hasche, G
Citation: K. Salmela et al., A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation - A report of the European anti-ICAM-1 renal transplant study group, TRANSPLANT, 67(5), 1999, pp. 729-736
Adrenal-sparing surgery for phaeochromocytoma
Authors: Neumann, HPH Bender, BU Reincke, M Eggstein, S Laubenberger, J Kirste, G
Citation: Hph. Neumann et al., Adrenal-sparing surgery for phaeochromocytoma, BR J SURG, 86(1), 1999, pp. 94-97
Pharmacokinetics of mycophenolic acid in the early period after kidney transplantation
Authors: Wollenberg, K Krumme, B Pisarski, P Schollmeyer, P Kirste, G
Citation: K. Wollenberg et al., Pharmacokinetics of mycophenolic acid in the early period after kidney transplantation, TRANSPLAN P, 30(8), 1998, pp. 4090-4091
Risultati: 1-17 |